(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PENZYME

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

PENZYME

ST13

US500000079411612

Classe

1, 3, 5

Pedido

79411612

Registro

8112758

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

32

Atualização mais recente

04/08/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 3, 5

Data de depósito

17/10/2024

Data de registro

27/01/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

27/01/2026

Última transação

04/08/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

SE

Examinador

SEVERSON, JUSTIN

Unidade examinadora

M20

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Enzymatica AB (publ)

Representantes

Maurine Knutsson Knutsson IP AB

Classificação técnica

Classes Nice

Classe 1Classe 3Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

enzyme substratesother than for medical or veterinary purposes; activator enzymes for use in the manufacture of mouth spraysnose sprayspharmaceuticalsnutraceuticalsfoodcosmetic preparationscosmetic formulationsskin care preparationspharmaceutical preparationscreams and lotions for skin care and skin treatmentdental preparationsdentifriceshair care preparationssoapsbath saltscosmeticsessential oilsperfumesnatural cosmetics; enzyme stabilizers; enzymes for scientific purposes; enzymes for industrial purposes; enzyme preparations for industrial purposes; enzyme substrates for scientific purposes; purified enzymes for industrial use; enzymesother than for medical or veterinary use

Classe 3

non-medicated skin care preparations; skin moisturizing gel and skin lotions; hair-care preparations; dentifricesdental care preparationsdental bleaching gels and creamsnon-medicated dental rinses; beautyskinbathbar soaps; perfumes; essential oils; cosmetics; natural cosmetics

Classe 5

pharmaceutical preparations for skin care and wounds; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating allergieshypertensionsunburnasthmahypoglycaemiadandruffchemical imbalancesdiabeteshalitosisskin disorders; pharmaceutical preparations for treatment and prevention of cardiovascularoncologicalpulmonarykidneyautoimmunemetabolicendocrinemusculoskeletalgenitourinaryneurologicalgastrointestinalhepatological diseases and disorders; pharmaceutical preparations for the treatment and prevention of damaged skin and tissueacneinfectious diseasespaininflammationsepsisalopeciaobesitycognitive disorderssleep disorderspsychiatric diseases and disordersviral infections and diseasesbacterial infections and diseases; veterinary preparationsantioxidants and pain relief medication; veterinary preparations for treatment of intestinal bacteria; veterinary pharmaceutical preparations for treatment and prevention of cardiovascularoncologicalpulmonarykidneyautoimmunemetabolicendocrinemusculoskeletalgenitourinaryneurologicalgastrointestinalhepatological diseases and disorders; veterinary pharmaceutical preparations for the treatment and prevention of damaged skin and tissueacneinfectious diseasespaininflammationsepsisalopeciaobesitycognitive disorderssleep disorderspsychiatric diseases and disordersviral infections and diseasesbacterial infections and diseases; medical preparations for preventing or treating colds being viral infections and diseases; medical preparationsgel and lotions for skin treatment; medicated mouth care preparations; chewing gums for medical purposes; sanitary preparations for medical purposes; dietetic substances adapted for medical usenutraceuticals for treatment and prevention of cardiovascularoncologicalpulmonarykidneyautoimmunemetabolicendocrinemusculoskeletalgenitourinaryneurologicalgastrointestinalhepatological diseases and disorders; dietetic substances adapted for medical usenutraceuticals for the treatment and prevention of damaged skin and tissueacneinfectious diseasespaininflammationsepsisalopeciaobesitycognitive disorderssleep disorderspsychiatric diseases and disordersviral infections and diseasesbacterial infections and diseases; dietetic substances adapted for medical usenutraceuticals for use as a dietary supplement; dietetic supplementsbeveragesfoodssugarsugar substitutesconfectionaries adapted for medical purposes and medical use; dietetic preparations adapted for medical purposes; medicinal drinks; vitamin preparations and mineral supplements; medicated bath preparations and medicated bath salts; medical plasters; materials for dressingsbandages for dressingsburn dressingsfirst aid dressingsmedical dressingssterilized dressingswound dressings; anti-inflammatory sprays; disinfectants; fungicidesherbicides; enzymes and enzyme preparations for medical purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

32 publicações encontradas

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/08/2026

FIMP

FINAL DISPOSITION PROCESSED

04/08/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

21/05/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/05/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/05/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

27/04/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

27/01/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

27/01/2026

GPNX

NOTIFICATION PROCESSED BY IB

11/12/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/12/2025

PUBO

PUBLISHED FOR OPPOSITION

09/12/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/12/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

26/11/2025

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

25/11/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/11/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

12/11/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/11/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

12/11/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/11/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/10/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/10/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/10/2025

RFNT

REFUSAL PROCESSED BY IB

07/06/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

21/05/2025

RFRR

REFUSAL PROCESSED BY MPU

21/05/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

28/03/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

26/03/2025

CNRT

NON-FINAL ACTION WRITTEN

25/03/2025

DOCK

ASSIGNED TO EXAMINER

24/03/2025

MAFR

APPLICATION FILING RECEIPT MAILED

09/12/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/12/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/12/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PENZYME ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.